PMO Interview with the Innovator Series: Volume 2

Peter Hirth, PhD

Video Categories: PMO Interview with the Innovator Series

The publishers of Personalized Medicine in Oncology (PMO) invite you to watch an interview with Peter Hirth, PhD, Chief Executive Officer of Plexxikon. In part one, Dr. Hirth discusses the use of biomarkers, segmenting the population of melanoma patients into subsets, and other aspects of personalized medicine.
November 24, 2014

Personalizing Cancer Treatment Based on Unique Genetic Profile

Gary Palmer, MD, explains how research is ahead of the physician and patient and the need to educate the physician and patient on all the information about DNA and what drives the cancer.

October 28, 2014

Options for Patients with Polycythemia Vera

Hear Dr. Mesa discuss options available for individual patients who have failed hydroxyurea polycythemia vera.Supported through funding from Incyte